Effectiveness of Trastuzumab in First-Line HER2+ Metastatic Breast Cancer After Failure in Adjuvant Setting: A Controlled Cohort Study

BACKGROUND. The evidence supporting the use of trastuzumab (T) in a metastatic setting comes from studies that included (almost) only patients who never received prior T. We investigated the effectiveness of T as first-line therapy for metastatic breast cancer (mBC) in women previously treated with...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: Negri, Eva, Zambelli, Alberto, Franchi, Matteo, Rossi, Marta, Bonifazi, Martina, Corrao, Giovanni, Moja, Lorenzo, Zocchetti, Carlo, La Vecchia, Carlo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2014
Onderwerpen:
Breast Cancer
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257745/
https://ncbi.nlm.nih.gov/pubmed/25355843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0227
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items